DE MICCO, ROSA
 Distribuzione geografica
Continente #
EU - Europa 863
NA - Nord America 660
AS - Asia 191
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.716
Nazione #
US - Stati Uniti d'America 658
IE - Irlanda 341
IT - Italia 253
SG - Singapore 85
CN - Cina 73
GB - Regno Unito 69
DE - Germania 56
UA - Ucraina 39
FR - Francia 34
SE - Svezia 22
GR - Grecia 20
TR - Turchia 18
FI - Finlandia 15
CZ - Repubblica Ceca 9
KR - Corea 8
IN - India 4
BE - Belgio 3
HK - Hong Kong 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
EU - Europa 1
JM - Giamaica 1
PH - Filippine 1
RO - Romania 1
Totale 1.716
Città #
Dublin 341
Santa Clara 135
Jacksonville 76
Singapore 64
New York 61
Chandler 56
Naples 44
Princeton 35
Bremen 33
Roxbury 33
Avella 27
Medford 23
Beijing 22
Napoli 18
Cambridge 13
Caserta 13
Wilmington 12
Boardman 11
Munich 11
Ashburn 10
Reggio Emilia 10
Brno 9
Des Moines 9
Helsinki 8
Seoul 8
Ann Arbor 7
London 7
Nanjing 7
Norwalk 7
Istanbul 6
Jinan 6
Rome 6
Casoria 5
Milan 5
Trento 5
Woodbridge 5
Ningbo 4
Acerra 3
Aversa 3
Brussels 3
Giugliano in Campania 3
Houston 3
Mountain View 3
Palermo 3
Philadelphia 3
Pune 3
Salerno 3
Shanghai 3
Zhengzhou 3
Afragola 2
Bovezzo 2
Caronno Pertusella 2
Cercola 2
Chengdu 2
Escondido 2
Genoa 2
Giugliano In Campania 2
Hangzhou 2
Hebei 2
Katrineholm 2
Los Angeles 2
Menlo Park 2
Nanchang 2
Padova 2
Portici 2
Redwood City 2
Rennes 2
San Giorgio a Cremano 2
San Mateo 2
Scanzano 2
Turin 2
Venice 2
Albanella 1
Avellino 1
Bologna 1
Boydton 1
Frattaminore 1
Gorgonzola 1
Jiaxing 1
Kunming 1
Lappeenranta 1
Olongapo City 1
Orange 1
Pognano 1
Pozzuoli 1
Rho 1
San Giuliano Milanese 1
Shenyang 1
São Paulo 1
Torre Del Greco 1
Vicenza 1
Vienna 1
Totale 1.254
Nome #
A transient third cranial nerve palsy as presenting sign of spontaneous intracranial hypotension 77
Medical retrofitting design 73
Clinical correlations of microstructural changes in progressive supranuclear palsy 68
Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. 64
Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease 63
Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients 55
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study 51
Olfactory loss and brain connectivity after COVID-19 51
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 50
Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach 48
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 47
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study 46
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders 45
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease 45
Fatigue in Parkinson's disease: A systematic review and meta-analysis 44
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease 44
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 39
Functional connectivity underpinnings of fatigue in "Drug-Naïve" patients with Parkinson's disease 38
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 35
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 35
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 33
Connectivity Correlates of Anxiety Symptoms in Drug-Naive Parkinson's Disease Patients 32
Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients 32
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 31
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 29
Brain Networks and Cognitive Impairment in Parkinson's Disease 29
Correlates of psychological distress in epileptic patients during the COVID-19 outbreak 29
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 29
Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients 28
Subjective memory decline in Parkinson's disease patients with and without fatigue 28
Validation of the Italian version of the PSP Quality of Life questionnaire 28
Structural MRI in Idiopathic Parkinson's Disease 26
Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment 26
Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study 25
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study 24
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak 23
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue 22
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 20
Sex-related pattern of intrinsic brain connectivity in drug-naïve Parkinson's disease patients 20
The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs 20
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 20
Functional Connectivity Signatures of Parkinson's Disease 19
Impulse control behaviors in Parkinson's disease: Drugs or disease? Contribution from imaging studies 18
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension 16
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 15
Speech Rhythm Variation in Early-Stage Parkinson's Disease: A Study on Different Speaking Tasks 15
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 14
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 14
Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment 13
Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients 13
Distinctive Handwriting Signs in Early Parkinson’s Disease 12
Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms 12
Olfactory Loss and Brain Connectivity after COVID-19: Structural Follow-Up at One Year 10
The Italian tremor Network (TITAN): rationale, design and preliminary findings 10
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 9
Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease 8
Functional motor phenotypes: to lump or to split? 8
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology 7
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 6
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age 5
Family History in Parkinson's Disease: A National Cross‐Sectional Study 4
Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease? 4
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 3
Correction to: Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 3
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study 2
Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications 2
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 2
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 2
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease 2
Molecular Imaging Markers to Track Huntington’s Disease Pathology 2
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 2
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum 2
Clinical correlates of “pure” essential tremor: the TITAN study 2
A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia 2
Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations 2
Totale 1.832
Categoria #
all - tutte 10.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202090 0 0 0 0 22 3 31 7 9 7 10 1
2020/2021136 5 2 11 8 26 3 29 11 5 9 24 3
2021/2022248 9 9 1 10 70 4 6 8 14 22 25 70
2022/2023506 44 8 6 23 54 19 2 13 312 14 5 6
2023/2024376 28 16 18 17 110 79 10 5 1 8 27 57
2024/2025284 8 28 7 29 212 0 0 0 0 0 0 0
Totale 1.832